Use of Amplification Refractory Mutation System PCR assay as a simple and effective 1 tool to detect HIV - 1 drug resistance mutations 2 Running title : Use ARMS - PCR to detect HIV drug resistance mutations 3 4
نویسندگان
چکیده
7 1. Department of Pathology, New York University School of Medicine, New York, NY, United 8 States 9 2. Department of Immunology and Applied Biotechnology, University of Rome “Tor Vergata”, 10 Rome, Italy 11 3. “Chantal Biya” International Reference Center, Sequencing Unit, Yaounde, Cameroon 12 4. Faculty of Sciences, University of Dschang, Dschang, Cameroon 13 5. Serology Unit, Medical Diagnostic Center, Yaounde, Cameroon 14 6. Internal Medicine Unit, Edéa Regional Hospital, Edéa, Cameroon 15 7. UNESCO Chair of Interdisciplinary Biotechnology, University of Rome "Tor Vergata", Rome, 16 Italy 17 8. Veterans Affairs New York Harbor Healthcare Systems, New York, NY, United States. 18 19 # Corresponding author: 20 Phillipe N. Nyambi 21 Department of Pathology, New York University School of Medicine, c/o V.A. Medical Center, 22 423 East 23rd Street, Room 18124N, New York, NY 10010, United States. 23 Tel.: +1 212 263 6769; fax: +1 212 951 6321; E-mail: [email protected] 24 JCM Accepted Manuscript Posted Online 18 March 2015 J. Clin. Microbiol. doi:10.1128/JCM.00114-15 Copyright © 2015, American Society for Microbiology. All Rights Reserved.
منابع مشابه
Comparison of the LiPA HIV-1 RT test, selective PCR and direct solid phase sequencing for the detection of HIV-1 drug resistance mutations.
The performance to detect drug resistance mutations in the reverse transcriptase gene of HIV-1 was compared for direct solid phase sequencing, selective polymerase chain reaction (PCR) using the amplification refractory mutation system (ARMS) and the new line probe assay (LIPA) HIV-1 RT. The three tests were undertaken on 50 plasma samples from 25 treatment-experienced patients under combinatio...
متن کاملEvaluation of Lamivudine Resistance Mutations in HBV/HIV Co-infected Patients
Background and Objective: The drug resistance mutations are key elements in the failure of long-term treatment of Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infections. The mutation in the YMDD motif in the P gene of HBV is the most critical factor in antiviral drug (especially lamivudine) resistance. This study aimed to assess the YMDD motif and other polymerase gene mutati...
متن کاملDrug-Resistant HIV-1 RT Gene Mutations in Patients under Treatment with Antiretroviral Drugs (HAART) in Iran
Abstract Background and Objective: Highly Active Antiretroviral Therapy (HAART) can effectively prevent the progression of HIV-1 replication and increase life expectancy. There are numerous causes of treatment failure and the leading one is drug resistance. Thus, we aimed to determine the HIV RT gene drug resistance mutations in patients treated with antiretroviral medications. Material...
متن کاملDrug Resistance Profile and Subtyping of HIV-1 RT Gene in Iranian Patients under Treatment
Identification of drug resistant mutations is important in the management of HIV-1 infected patients. The aim of the current study was to evaluate drug resistance profile of RT gene and assess subtype among HIV-1 circulating strains and intensification of physician’s options for the best therapy. HIV-1 RNA of 25 sampleswas extracted from plasma and RT Nested- PCR was performed and the fin...
متن کاملAnalysis of HIV-1 variants by cloning DNA generated with the ViroSeq HIV-1 Genotyping System.
There are three major classes of antiretroviral drugs approved in the United States for treatment of human immunodeficiency virus type 1 (HIV-1) infection: protease inhibitors, nucleoside and nucleotide reverse transcriptase inhibitors, and non-nucleoside reverse transcriptase inhibitors (NNRTIs). Unfortunately, the efficacy of these drugs is often limited by HIV-1 drug resistance, which is usu...
متن کامل